National Institutes of Health
Federal agency · 821 grants in this directory · 721 currently open · page 5 of 17
The National Institutes of Health is a United States federal agency that administers research and development funding. It supports health and medical research across areas including oncology, infectious diseases, aging, cognitive health, autoimmune conditions, and complementary interventions, as well as the development of diagnostic and therapeutic devices. Applicants include educational institutions, nonprofits, small businesses, tribal governments, and individuals pursuing fellowships or workforce training opportunities.
Open grants (50)
- BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)Funding amount not specified · Closes June 15, 2027
- Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)Funding amount not specified · Closes June 17, 2027
- Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)Funding amount not specified · Closes July 2, 2027
- NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required)Funding amount not specified · Closes July 12, 2027
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)Funding amount not specified · Closes July 12, 2027
- NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed)Funding amount not specified · Closes July 12, 2027
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)Funding amount not specified · Closes July 17, 2027
- Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)Up to $150K · Closes August 11, 2027
- Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)Funding amount not specified · Closes August 18, 2027
- Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)Funding amount not specified · Closes September 7, 2027
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)Funding amount not specified · Closes September 7, 2027
- Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)Funding amount not specified · Closes September 7, 2027
- Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)Funding amount not specified · Closes September 7, 2027
- Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)Funding amount not specified · Closes September 7, 2027
- Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)Funding amount not specified · Closes September 7, 2027
- D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional)Up to $100K · Closes September 7, 2027
- Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)Funding amount not specified · Closes September 7, 2027
- Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)Funding amount not specified · Closes September 10, 2027
- NICHD Resource Program Grants in Bioinformatics (P41 Clinical Trial Not Allowed)Funding amount not specified · Closes September 25, 2027
- Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)Funding amount not specified · Closes September 28, 2027
- Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)Funding amount not specified · Closes September 28, 2027
- Clinical and Translational Science Award (UM1 Clinical Trial Optional)Funding amount not specified · Closes September 28, 2027
- Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)Funding amount not specified · Closes September 28, 2027
- Research Experiences and/or Mentoring Networks through Research Education to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed)Up to $250K · Closes September 29, 2027
- BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)Funding amount not specified · Closes October 4, 2027
- Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)Funding amount not specified · Closes October 8, 2027
- Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)Funding amount not specified · Closes October 8, 2027
- NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional)Up to $500K · Closes October 12, 2027
- NCI Pathway to Independence Award (K99/R00 Clinical Trial Required)Funding amount not specified · Closes October 14, 2027
- NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)Funding amount not specified · Closes October 14, 2027
- Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required)Funding amount not specified · Closes October 15, 2027
- Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)Funding amount not specified · Closes October 15, 2027
- First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)Funding amount not specified · Closes October 15, 2027
- Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 Clinical Trial Required)Funding amount not specified · Closes October 15, 2027
- NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)Funding amount not specified · Closes October 15, 2027
- Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)Funding amount not specified · Closes October 15, 2027
- Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)Funding amount not specified · Closes October 15, 2027
- Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required)Funding amount not specified · Closes October 15, 2027
- Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)Funding amount not specified · Closes October 15, 2027
- Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)Funding amount not specified · Closes October 15, 2027
- NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)Funding amount not specified · Closes October 16, 2027
- NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)Funding amount not specified · Closes October 18, 2027
- Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)$50K – $300K · Closes October 19, 2027
- Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)Up to $650K · Closes October 19, 2027
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)Up to $750K · Closes October 20, 2027
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)Funding amount not specified · Closes October 20, 2027
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)Up to $750K · Closes October 20, 2027
- National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)Funding amount not specified · Closes October 25, 2027
- Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)Funding amount not specified · Closes October 25, 2027
- Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)Funding amount not specified · Closes October 25, 2027
GrantRegister provides information, not advice. Eligibility requirements and deadlines are set by the funder and can change without notice. Confirm eligibility, deadlines, and requirements with National Institutes of Health before applying.